Cantor Fitzgerald Reiterates Overweight Rating, $95 Price Target on I-Mab (IMAB), Expects "Greater Appreciation for the Company's Pipeline"

Go back to Cantor Fitzgerald Reiterates Overweight Rating, $95 Price Target on I-Mab (IMAB), Expects "Greater Appreciation for the Company's Pipeline"
(NASDAQ: IMAB) Delayed: 4.63 --0 (-0%)
Previous Close $4.63    52 Week High
Open $4.63    52 Week Low
Day High $4.63    P/E N/A 
Day Low $4.63    EPS
Volume 608